INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
HS

Hackman Jeffrey S.

Director, Chief Executive OfficerCIK 0001926254

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    FENNEC PHARMACEUTICALS INC.Director, Chief Executive Officer · May 1, 2026
9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A
$12K
2,224 sh
Oct 12, 2026
Oct 13, 2026
traded Oct 12, 2026
+1d
SEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
May 31, 2026Jun 1, 2026
traded May 31, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
1,159 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence